Humana Reaffirms 2026 Earnings Guidance in Investor Meetings
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Humana ( (HUM) ) is now available.
Between March 2 and March 31, 2026, Humana’s senior management planned to meet with investors and analysts to discuss the company’s outlook for the year ending December 31, 2026. During these meetings, the company said it would reaffirm its full-year 2026 guidance of at least $8.89 in diluted earnings per share and at least $9.00 in adjusted earnings per share, in line with guidance issued on February 11, 2026.
Humana highlighted its use of adjusted, non-GAAP EPS as a key tool for evaluating core operating performance over time, planning, decision-making, and incentive compensation, while cautioning that this metric has limitations and differs from GAAP. The company noted that while it does not expect changes to its adjusted EPS outlook for 2026, GAAP EPS guidance could change as a result of ongoing value creation and other strategic initiatives, a distinction that may influence how investors assess the quality and sustainability of its earnings.
The most recent analyst rating on (HUM) stock is a Buy with a $235.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.
Spark’s Take on HUM Stock
According to Spark, TipRanks’ AI Analyst, HUM is a Neutral.
The score is weighed down primarily by weakening profitability and a sharp deterioration in 2025 operating/free cash flow, reinforced by conservative 2026 guidance driven by the ~$3.5B STARS headwind and margin pressure. Technicals also remain strongly negative with the stock well below key moving averages. Valuation and the dividend offer some support but are not sufficient to offset near-term fundamentals and outlook risks.
To see Spark’s full report on HUM stock, click here.
More about Humana
Humana Inc. is a health insurance company that provides medical and specialty benefits, with a focus on Medicare, Medicaid, and commercial health plans in the U.S. The company emphasizes managed care and value-based models to serve individuals, employers, and government-funded programs, positioning itself as a major player in the U.S. health benefits and services market.
Average Trading Volume: 1,962,933
Technical Sentiment Signal: Sell
Current Market Cap: $22.98B
See more insights into HUM stock on TipRanks’ Stock Analysis page.
